MedTrace Logo

Bioavailability and Dosing of a Monosaccharide Supplement in Adults

NCT00782392 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2011-05-18

No results posted yet for this study

Summary

We are developing an oral supplement of carbohydrates to be added to infant formulas in order to improve brain development, immune function, and overall health of infants and children. After a careful review of what is known about these sugars, there is very little information regarding their use in infants and children, although there is some information in adults and animals.

Many of these sugars have been used in a glyco-nutritional supplement in adults and children, with minimal or no reported side effects.

We are developing a custom blend of important individual sugars, and need information regarding their dosing and blood concentrations following oral intake of the carbohydrate supplement. Timed blood samples following the carbohydrate supplement will provide us with a better understanding of the most effective dose and the metabolism of these sugars in adults. This will give us the preliminary information we need for developing an oral supplement of special sugars that can be added to infant formulas to help improve brain development and immune function in infants and children.

Conditions

  • Healthy Males

Sponsors & Collaborators

  • University of Arkansas

    collaborator OTHER

  • United States Department of Agriculture (USDA)

    collaborator FED

  • Arkansas Children's Hospital Research Institute

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
28 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00782392 on ClinicalTrials.gov